Drug intelligence / Profile preview

Linola sept Antivirale Mund- und Rachenspülung

Development stage
Preclinical
Lead developer
Dr August Wolff
Administration
Topical
01

Overview

**Linola sept Antivirale Mund- und Rachenspülung** is an alcohol-free antiviral mouth-and-throat rinse marketed by Dr. Wolff as a medical device. It is a locally applied surfactant-containing formulation intended to help inactivate and remove specific enveloped viruses in the oral cavity and throat. Its listed ingredients include sodium lauryl sulfate, sodium methyl cocoyl taurate, sodium myristoyl sarcosinate, PEG-40 hydrogenated castor oil, zinc PCA, hydroxyapatite, lactoferrin, and sodium hyaluronate. The proposed antiviral action is non-specific physicochemical disruption of the viral lipid envelope rather than binding to a defined human receptor. A completed randomized placebo-controlled registered study evaluated gargling with the product in people with COVID-19, and the product has also been studied for rhinovirus-associated acute sore throat symptoms. ([linola.com](https://www.linola.com/de-de/cremes-shampoos-co/details/product/linola-sept-antivirale-mund-und-rachenspuelung))

Brand names
Linola sept Antivirale Mund- und Rachenspülung
Other names
Linola sept Antiviral Mouth and Throat RinseLinola sept mouthwashLinola sept Mund- und Rachenspülung
02

Targets

BVDV E2 (Bovine viral diarrhea virus glycoprotein E2)

Beyond the preview

Go deeper on Linola sept Antivirale Mund- und Rachenspülung.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Linola sept Antivirale Mund- und Rachenspülung.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call